MGRX vs. BRTX, GBNHF, OTRK, PULM, TENX, SHPH, IBIO, LFLY, ASLN, and INBS
Should you be buying Mangoceuticals stock or one of its competitors? The main competitors of Mangoceuticals include BioRestorative Therapies (BRTX), Greenbrook TMS (GBNHF), Ontrak (OTRK), Pulmatrix (PULM), Tenax Therapeutics (TENX), Shuttle Pharmaceuticals (SHPH), iBio (IBIO), Leafly (LFLY), ASLAN Pharmaceuticals (ASLN), and Intelligent Bio Solutions (INBS). These companies are all part of the "medical" sector.
BioRestorative Therapies (NASDAQ:BRTX) and Mangoceuticals (NASDAQ:MGRX) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, institutional ownership, valuation, community ranking, profitability, risk, analyst recommendations, dividends and media sentiment.
69.4% of BioRestorative Therapies shares are held by institutional investors. Comparatively, 56.7% of Mangoceuticals shares are held by institutional investors. 21.6% of BioRestorative Therapies shares are held by insiders. Comparatively, 46.4% of Mangoceuticals shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Mangoceuticals has a net margin of -1,260.81% compared to Mangoceuticals' net margin of -9,873.97%. Mangoceuticals' return on equity of -114.84% beat BioRestorative Therapies' return on equity.
Mangoceuticals has higher revenue and earnings than BioRestorative Therapies.
In the previous week, BioRestorative Therapies had 2 more articles in the media than Mangoceuticals. MarketBeat recorded 5 mentions for BioRestorative Therapies and 3 mentions for Mangoceuticals. BioRestorative Therapies' average media sentiment score of 1.43 beat Mangoceuticals' score of 0.39 indicating that Mangoceuticals is being referred to more favorably in the news media.
BioRestorative Therapies and Mangoceuticals both received 0 outperform votes by MarketBeat users.
BioRestorative Therapies has a beta of 62.12, indicating that its share price is 6,112% more volatile than the S&P 500. Comparatively, Mangoceuticals has a beta of 1.27, indicating that its share price is 27% more volatile than the S&P 500.
Summary
BioRestorative Therapies beats Mangoceuticals on 6 of the 11 factors compared between the two stocks.
Get Mangoceuticals News Delivered to You Automatically
Sign up to receive the latest news and ratings for MGRX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding MGRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Mangoceuticals Competitors List
Related Companies and Tools
